Skip to main content

Heart health risk of prostate cancer treatment being ignored, warn specialists

Heart disease and stroke are emerging complications of treating prostate cancer with testosterone suppression, yet standard management of the disease is ignoring this risk, warn specialists in a viewpoint by researchers at Queen Mary University of London.

Published on:
Back to top